{
  "docId": "019de075-6448-707d-82ec-cbbeebb7feb3",
  "docSlug": "1eef6abd03697885c8a70f789c554a37",
  "documentTitle": "Nuvectis Pharma | Investor Presentation Deck | 23 slides",
  "authorId": "nuvectis-pharma",
  "authorName": "Nuvectis Pharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 23,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "Includes a detailed biological pathway diagram and a Western blot image as evidence.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-6448-707d-82ec-cbbeebb7feb3/8",
  "deckHref": "/decks/019de075-6448-707d-82ec-cbbeebb7feb3",
  "deckJsonHref": "/decks/019de075-6448-707d-82ec-cbbeebb7feb3.json",
  "deckAnchorHref": "/decks/019de075-6448-707d-82ec-cbbeebb7feb3#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.35,
        "x": 0.62,
        "y": 0.875
      },
      "kind": "callout",
      "text": "ATF4 induction observed in patient samples in the phase 1a",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "298fb936-d927-417f-90c1-49dd806ff9f3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.11,
        "w": 0.35,
        "x": 0.62,
        "y": 0.175
      },
      "kind": "callout",
      "text": "ATF4 was induced in vivo in SKOV3 xenografts; ATF4 Validated as biomarker for preclinical activity",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e755af0-93c4-4d5f-a029-d181c1058c7f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.11,
        "w": 0.52,
        "x": 0.03,
        "y": 0.175
      },
      "kind": "callout",
      "text": "NXP800 activates GCN2 >> GCN2 activates the Integrated Stress Response (ISR) >> ISR activation causes a translational switch which includes downregulation of HSF1-regulated genes",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e81d85c2-9c25-4e37-bf8c-a405a9ac3a8a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.52,
        "x": 0.03,
        "y": 0.31
      },
      "kind": "diagram",
      "text": "Biological pathway diagram showing GCN2 activation, eIF2a phosphorylation, and ATF4 translation.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c6fb647-b991-48cc-a8e3-9a551bdac296",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.25,
        "x": 0.67,
        "y": 0.31
      },
      "kind": "image",
      "text": "Western blot showing ATF4 induction in Vehicle vs X5 treated samples.",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "22f32f7c-20d7-4f0a-bd93-20ee7d4f81e2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.15,
        "x": 0.67,
        "y": 0.825
      },
      "kind": "source-note",
      "text": "Clarke et al, ENA 2022",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1590fdb2-f1ec-4082-85a4-71dcaa5e4f4a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "NXP800 Mechanism of Action",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "41b67002-492d-4e14-b46e-3c4b73043439",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "NXP800 is a GCN2 kinase activator",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e69f9c3e-d986-439d-961c-7cf7980a5f53",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "causal-chain",
      "slug": null,
      "matchId": "a82b0917-936b-4873-aa3b-0ecf3e5674a1",
      "evidence": "The diagram maps the sequential activation from NXP800 to HSF1 downregulation.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 11,
      "from": 7,
      "beatId": "f389e115-9cf2-445c-99f9-4a0bb1433753",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The deck presents the mechanism of action and key highlights of NXP800 and NXP900.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}